Fondaparinux Sodium contains not less than 95.0% and not more than 103.0% of C13H43N3O49S8Na10, calculated on the anhydrous substance.

共有 1 個藥物證書使用此成份

磺達肝素鈉鹽
Fondaparinux Sodium

• 申請商: 台灣荃新股份有限公司
• 適應症: 抗血栓藥
• 發證日期: 2023-03-01